| Quantity: | |
|---|---|
【COMPOSITION AND CONTENT】
This product contains cell-cultured attenuated lapinized swine fever virus.
【CHARACTER】
Milky white spongy loose mass, easily detached from the bottle wall and rapidly soluble after adding diluent.
【INDICATIONS】
For the prevention of classical swine fever. Protective immunity develops 4 days after vaccination. The immune duration lasts 12 months for weaned piglets without maternal antibodies.
【DOSAGE AND ADMINISTRATION】
Dilute the vaccine with normal saline according to the doses specified on the vial label. Administer 1.0 mL per pig of all ages via intramuscular or subcutaneous injection.
In areas free of swine fever epidemic, a single vaccination is sufficient for weaned piglets without maternal antibodies. In areas under epidemic threat, piglets shall be vaccinated twice at approximately 21–30 days of age and 65 days of age respectively.
Piglets before weaning may be vaccinated with 4 doses to prevent immune interference caused by maternal antibodies.
【PRESENTATION】
20 doses/vial, 40 doses/vial, 50 doses/vial, 60 doses/vial
【STORAGE AND SHELF LIFE】
Store at 2–8 °C. Shelf life: 24 months from the date of manufacture.
For use only under veterinary supervision.
1. Classic lapinized attenuated strain for targeted swine fever prevention: Refined from classic swine fever lapinized attenuated strain with stable performance, mild virulence and strong immunogenicity. It is a classic special strain for domestic swine fever prevention, effectively avoiding swine fever outbreak, latent infection and vertical transmission risks for pig farms.
2. Fast immune onset and ultra-long full-year protection: Effective protective immunity is produced only 4 days after vaccination to fill the immune gap rapidly. The immune duration lasts up to 12 months for weaned piglets without maternal antibodies, providing full-year stable protection covering the whole pig breeding and fattening cycle.
3. Unique heat-resistant formulation improves storage tolerance: Equipped with special heat-resistant protectant, the vaccine has stronger heat resistance and more stable antigen activity than ordinary swine fever vaccines. It avoids activity attenuation caused by temperature fluctuation and reduces transportation and storage loss significantly.
4. Hierarchical scientific immune procedure adapts to pigs at all stages: Customized immune schemes fit different epidemic scenarios and pig ages. Single vaccination works in non-epidemic areas, double booster vaccination is adopted in epidemic-threatened areas, and advance vaccination before weaning eliminates maternal antibody interference to avoid immune failure.
5. Unified dosage for all pigs with simple and efficient operation: A fixed 1.0ml standard dosage for all pigs regardless of age and size eliminates grouping and weighing operations. It simplifies large-scale batch immunization procedures and significantly improves farm epidemic prevention efficiency.
6. Dual flexible vaccination methods adapt to full breeding scenarios: Supports both intramuscular and subcutaneous injection with minimal trauma and simple operation. It adapts to various breeding scales and operation habits, fully meeting the batch immunization needs of all types of pig farms.
7. Pure cell-derived technology with ultra-low immune stress: Refined by high-purity cell culture technology with few impurities and pure antigen activity. No adverse reactions occur after vaccination, with no impact on pig feeding, growth and fattening performance.
Q: What type of vaccine is this? What diseases does it prevent?
A: This is a heat-resistant live swine fever vaccine (cell-derived), a non-prescription veterinary drug prepared from swine fever lapinized attenuated strain, specially used for the prevention of swine fever and serving as a core basic vaccine for pig farm biosafety.
Q：What are the core advantages and protection characteristics of the vaccine?
A: Adopting classic lapinized attenuated strain, the vaccine features fast immune onset in 4 days and strong immunogenicity. With heat-resistant formulation, stable storage performance, 12-month long protection, unified dosage and dual vaccination methods, it achieves efficient and comprehensive swine fever prevention.
Q: What is the optimal immune procedure for different epidemic scenarios?
A: Non-epidemic areas: single vaccination for weaned piglets without maternal antibodies; epidemic-threatened areas: primary vaccination at 21–30 days old and booster at about 65 days old; advance vaccination with 4 doses for pre-weaning piglets eliminates maternal antibody interference.
Q: What are the immune onset time and maximum protection duration?
A: Effective protective immunity is formed on the 4th day after standard vaccination to block infection rapidly. The immune duration lasts up to 12 months for weaned piglets without maternal antibodies, providing full-year stable protection.
